))
Chikungunya Vaccine Trial: Exploring the Results
Manage episode 436702581 series 3517021
محتوای ارائه شده توسط ReachMD. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط ReachMD یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Host: Matt Birnholz, MD
Chikungunya is a mosquito-transmitted viral disease that is highly likely to spread globally through patients who are traveling. So a phase three clinical trial aimed to test the safety and immunogenicity of the VLA1553 vaccine against this virus. Dive in to learn about the methods and results of this trial with Dr. Matt Birnholz, ReachMD host. Valneva did not contribute to the educational content.
…
continue reading
Chikungunya is a mosquito-transmitted viral disease that is highly likely to spread globally through patients who are traveling. So a phase three clinical trial aimed to test the safety and immunogenicity of the VLA1553 vaccine against this virus. Dive in to learn about the methods and results of this trial with Dr. Matt Birnholz, ReachMD host. Valneva did not contribute to the educational content.
37 قسمت
اشتراک گذاری
